BE899777A - DERIVATIVES WITH THERAPEUTIC ACTIVITY OF S-CARBOXYMETHYLCYSTEINE, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. - Google Patents

DERIVATIVES WITH THERAPEUTIC ACTIVITY OF S-CARBOXYMETHYLCYSTEINE, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Info

Publication number
BE899777A
BE899777A BE0/213024A BE213024A BE899777A BE 899777 A BE899777 A BE 899777A BE 0/213024 A BE0/213024 A BE 0/213024A BE 213024 A BE213024 A BE 213024A BE 899777 A BE899777 A BE 899777A
Authority
BE
Belgium
Prior art keywords
carboxymethylcysteine
therapeutic activity
derivatives
preparation
pharmaceutical compositions
Prior art date
Application number
BE0/213024A
Other languages
French (fr)
Original Assignee
Pavese Ist Biochim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavese Ist Biochim filed Critical Pavese Ist Biochim
Publication of BE899777A publication Critical patent/BE899777A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Dérivé à activité thérapeutique de la S-carboxyméthylcystéine répondant à la formule générale I dans laquelle X est choisi entre l'hydrogène, un métal alcalin, un métal alcalino-terreux, un radical d'une base organique ou inorganique non toxique et pharmaceutiquement acceptable, d'un amino-acide basique ou d'un antibiotique basique, et Y est choisi entre l'hydrogène, un métal alcalin et un métal alcalino-terreux, et dans laquelle, en outre, lorsque X ou respectivement Y est un radical d'une base organique ou inorganique, d'un amino-acide basique ou d'un antibiotique basique, Y ou respectivement X est différent de l'hydrogène.Derivative with therapeutic activity of S-carboxymethylcysteine corresponding to the general formula I in which X is chosen from hydrogen, an alkali metal, an alkaline earth metal, a radical of a non-toxic and pharmaceutically acceptable organic or inorganic base, of a basic amino acid or of a basic antibiotic, and Y is chosen from hydrogen, an alkali metal and an alkaline earth metal, and in which, moreover, when X or respectively Y is a radical of an organic or inorganic base, a basic amino acid or a basic antibiotic, Y or X respectively is different from hydrogen.

BE0/213024A 1983-05-30 1984-05-29 DERIVATIVES WITH THERAPEUTIC ACTIVITY OF S-CARBOXYMETHYLCYSTEINE, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. BE899777A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21358/83A IT1164255B (en) 1983-05-30 1983-05-30 DERIVATIVES FROM THERAPEUTIC ACTIVITIES OF S-CARBOXYMETHYLCISTEIN, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (1)

Publication Number Publication Date
BE899777A true BE899777A (en) 1984-09-17

Family

ID=11180631

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213024A BE899777A (en) 1983-05-30 1984-05-29 DERIVATIVES WITH THERAPEUTIC ACTIVITY OF S-CARBOXYMETHYLCYSTEINE, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Country Status (5)

Country Link
BE (1) BE899777A (en)
CH (1) CH661511A5 (en)
ES (1) ES532870A0 (en)
FR (1) FR2549057B1 (en)
IT (1) IT1164255B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334344A1 (en) * 1975-12-10 1977-07-08 Chauvin Blache Sa Laboratoires Hydroxyphenyl-alkanolamine acyl cysteinates - give stable aq. solns. suitable for use in ophthalmic compsns.
FR2430945A2 (en) * 1978-07-12 1980-02-08 Chauvin Blache Lab Anti-bronchitic N-thenoyl derivs. of cysteine - for admin. orally or as aerosol sprays
FR2502627A1 (en) * 1981-02-02 1982-10-01 Refarmed Sa THIOLIC DERIVATIVES OF ERYTHROMYCIN WITH THERAPEUTIC ACTIVITY, PROCESS FOR PREPARATION AND PHARMACEUTICAL PRODUCTS IN WHICH THEY APPEAR

Also Published As

Publication number Publication date
IT1164255B (en) 1987-04-08
ES8505644A1 (en) 1985-06-16
CH661511A5 (en) 1987-07-31
FR2549057B1 (en) 1987-01-16
ES532870A0 (en) 1985-06-16
FR2549057A1 (en) 1985-01-18
IT8321358A0 (en) 1983-05-30
IT8321358A1 (en) 1984-11-30

Similar Documents

Publication Publication Date Title
ES8801659A1 (en) Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them.
MY101791A (en) New benzimidazole derivatives
ES8506615A1 (en) N-aryl-alpha-amino-carboxamides.
AU572978B2 (en) 1,5-benzothiazepine derivatives
AU552908B2 (en) 4 n-phenyl benzyl-aminomethyl-imidazole
DK0598770T3 (en) Pyrazine derivatives and their preparation and use
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
DE3587362D1 (en) BENZO-CONDENSED HETEROCYCLIC COMPOUND.
ATE40127T1 (en) 1,5-BENZOTHIAZEPINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND MEDICATIONS.
BE899777A (en) DERIVATIVES WITH THERAPEUTIC ACTIVITY OF S-CARBOXYMETHYLCYSTEINE, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
EP0272596A3 (en) Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivates, a method for their preparation and pharmaceutical compositions in which they are included
ATE50248T1 (en) AN IMIDAZOLIDINETRIONE DERIVATIVE OR A PHARMACEUTICAL COMPOSITION CONTAINING ITS PHARMACEUTICALLY ACCEPTABLE SALTS.
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
RU94021365A (en) DERIVATIVES OF METHYLPIPERAZINAZEPENINE, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND USE OF DERIVATIVES AS A PHARMACEUTICAL ACTIVE SUBSTANCE
KR900016156A (en) Quinoxaline derivatives and ulcers
FI860098A (en) NYA PIPERAZINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION SOM INNEHAOLLER DESSA FOERENINGAR SOM AKTIV INGREDIENS.
FR2344545A1 (en) (2-PYRIMIDINYLTHIO) -ALKANOIC ACID AMIDES HAVING ANTILIPEMIC ACTIVITY, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MY103952A (en) Aqueous formulations containing a piperidinylcyclopentyheptenoic acid derivative
ATE36957T1 (en) N,N-DIETHYL-5-METHYL-2H,1-BENZOTHIOPYRANO-(4,3,-CD)-INDAZOLE-2-ETHANAMINE, THE PREPARATIONS CONTAINING THEM AND THEIR USE.
EP0124252A3 (en) Double ester of 16beta-ethylestran-17beta-ol derivatives
ES8703872A1 (en) 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives.
IT8420353A0 (en) ESTER OF THEOPHYLLINE-7-ACETIC ACID WITH D,L-TRANS-SOBREROLE HAVING MUCOSECRETOLYTIC-PLUIDIFYING AND ANTIBRONCHOSPASTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND ITS PHARMACEUTICAL COMPOSITIONS.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
KR860002498A (en) Pharmaceutical Compositions of 1,4-Dihydropyridine Derivatives
TNSN86108A1 (en) HETEROCYCLIC PENTALENE DERIVATIVES FOR USE IN THE FIGHT AGAINST MICROORGANISMS

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ISTITUTO BIOCHIMICO PAVESE S.P.A.

Effective date: 19930531